Ventricular Fibrillation Pulseless Ventricular Tachycardia - Revision history

Treloars at 12:56, 27 June 2023

2023-06-27T12:56:36Z

← Older revision		Revision as of 12:56, 27 June 2023
Line 41:		Line 41:
	** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)		** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)
	* Administer [[Epinephrine\|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest		* Administer [[Epinephrine\|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest
	~~:'''OR'''~~
	* Administer [[Vasopressin\|VASOPRESSIN]] 40 units IV / IO – replaces the first or second dose of epinephrine
	** Vasopressin is a one-time dose
	** Do not stop CPR to administer medications
	* Reassess for circulation every two minutes		* Reassess for circulation every two minutes
	** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic		** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic

Treloars at 14:42, 24 April 2020

2020-04-24T14:42:53Z

← Older revision		Revision as of 14:42, 24 April 2020
Line 42:		Line 42:
	* Administer [[Epinephrine\|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest		* Administer [[Epinephrine\|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest
	:'''OR'''		:'''OR'''
	* Administer [[~~Hormones Vitamins~~\|VASOPRESSIN]] 40 units IV / IO – replaces the first or second dose of epinephrine		* Administer [[Vasopressin\|VASOPRESSIN]] 40 units IV / IO – replaces the first or second dose of epinephrine
	** Vasopressin is a one-time dose		** Vasopressin is a one-time dose
	** Do not stop CPR to administer medications		** Do not stop CPR to administer medications

Treloars at 13:44, 24 April 2020

2020-04-24T13:44:58Z

← Older revision		Revision as of 13:44, 24 April 2020
Line 58:		Line 58:
	** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[Lidocaine\|LIDOCAINE]] DRIP 1-4 mg/min.		** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[Lidocaine\|LIDOCAINE]] DRIP 1-4 mg/min.
	** In patients over age 70 or in those with known hepatic disease, administer [[Lidocaine\|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.		** In patients over age 70 or in those with known hepatic disease, administer [[Lidocaine\|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.
	* Administer [[~~Electrolytes~~\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)		* Administer [[Magnesium Sulfate\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)
	* Administer [[~~Electrolytes~~\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD		* Administer [[Sodium Bicarbonate\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD

	'''If patient combative post resuscitation, refer to [[Analgesia and Sedation\|ANALGESIA / SEDATION PARAMETER (2.04)]]'''		'''If patient combative post resuscitation, refer to [[Analgesia and Sedation\|ANALGESIA / SEDATION PARAMETER (2.04)]]'''

Treloars at 23:37, 23 April 2020

2020-04-23T23:37:39Z

← Older revision		Revision as of 23:37, 23 April 2020
Line 50:		Line 50:
	''If after 3 attempts at defibrillation and patient is still presenting VF, consider using double sequential defibrillation for subsequent shocks at 720j biphasic. If two manual monitors are not available, use one monitor and one AED even though they will not be able to deliver full 720j. (using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])		''If after 3 attempts at defibrillation and patient is still presenting VF, consider using double sequential defibrillation for subsequent shocks at 720j biphasic. If two manual monitors are not available, use one monitor and one AED even though they will not be able to deliver full 720j. (using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])
	* Administer antidysrhythmic medication:		* Administer antidysrhythmic medication:
	** [[~~Antiarrhythmics~~\|AMIODARONE]] 300 mg IVP, IO.		** [[Amiodarone\|AMIODARONE]] 300 mg IVP, IO.
	** May repeat second dose [[~~Antiarrhythmics~~\|AMIODARONE]] (if needed) 150 mg IV, IO in 3-5 minutes.		** May repeat second dose [[Amiodarone\|AMIODARONE]] (if needed) 150 mg IV, IO in 3-5 minutes.
	*** Maximum dose 450 mg.		*** Maximum dose 450 mg.
	:'''OR'''		:'''OR'''
	* Administer [[~~Antiarrhythmics~~\|LIDOCAINE]] 1 to 1.5 mg/kg IVP, IO. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.		* Administer [[Lidocaine\|LIDOCAINE]] 1 to 1.5 mg/kg IVP, IO. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.
	** In patients over age 70 or in those with known hepatic disease, administer [[~~Antiarrhythmics~~\|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.		** In patients over age 70 or in those with known hepatic disease, administer [[Lidocaine\|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.
	** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[~~Antiarrhythmics~~\|LIDOCAINE]] DRIP 1-4 mg/min.		** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[Lidocaine\|LIDOCAINE]] DRIP 1-4 mg/min.
	** In patients over age 70 or in those with known hepatic disease, administer [[~~Antiarrhythmics~~\|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.		** In patients over age 70 or in those with known hepatic disease, administer [[Lidocaine\|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.
	* Administer [[Electrolytes\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)		* Administer [[Electrolytes\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)
	* Administer [[Electrolytes\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD		* Administer [[Electrolytes\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD

Treloars at 20:01, 22 April 2020

2020-04-22T20:01:46Z

← Older revision		Revision as of 20:01, 22 April 2020
Line 40:		Line 40:
	** Do not interrupt compressions to place an advanced airway		** Do not interrupt compressions to place an advanced airway
	** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)		** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)
	* Administer [[~~Adrenergics~~\|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest		* Administer [[Epinephrine\|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest
	:'''OR'''		:'''OR'''
	* Administer [[Hormones Vitamins\|VASOPRESSIN]] 40 units IV / IO – replaces the first or second dose of epinephrine		* Administer [[Hormones Vitamins\|VASOPRESSIN]] 40 units IV / IO – replaces the first or second dose of epinephrine

Treloars at 15:44, 1 February 2018

2018-02-01T15:44:54Z

← Older revision		Revision as of 15:44, 1 February 2018
Line 68:		Line 68:

	[[File:Adult_Cardiac_Arrest_Flowchart.jpg\|500px]]		[[File:Adult_Cardiac_Arrest_Flowchart.jpg\|500px]]

			[[Category:Cardiac\|0408]]

Treloars: /* 4.08 CARDIAC ARREST - VENTRICULAR FIBRILLATION /PULSELESS VENTRICULAR TACHYCARDIA */

2017-01-06T16:55:47Z

4.08 CARDIAC ARREST - VENTRICULAR FIBRILLATION /PULSELESS VENTRICULAR TACHYCARDIA

← Older revision		Revision as of 16:55, 6 January 2017
Line 48:		Line 48:
	** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic		** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic
	** Subsequent shocks should be at the higher dose selected		** Subsequent shocks should be at the higher dose selected
	''If after 3 attempts at defibrillation and patient is still presenting VF, ~~each~~ subsequent ~~shock should be delivered~~ at ~~'''''~~720j biphasic~~'''''~~(using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])		''If after 3 attempts at defibrillation and patient is still presenting VF, consider using double sequential defibrillation for subsequent shocks at 720j biphasic. If two manual monitors are not available, use one monitor and one AED even though they will not be able to deliver full 720j. (using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])
	* Administer antidysrhythmic medication:		* Administer antidysrhythmic medication:
	** [[Antiarrhythmics\|AMIODARONE]] 300 mg IVP, IO.		** [[Antiarrhythmics\|AMIODARONE]] 300 mg IVP, IO.

Treloars at 17:01, 28 December 2016

2016-12-28T17:01:32Z

← Older revision		Revision as of 17:01, 28 December 2016
Line 48:		Line 48:
	** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic		** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic
	** Subsequent shocks should be at the higher dose selected		** Subsequent shocks should be at the higher dose selected
			''If after 3 attempts at defibrillation and patient is still presenting VF, each subsequent shock should be delivered at '''''720j biphasic'''''(using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])
	* Administer antidysrhythmic medication:		* Administer antidysrhythmic medication:
	** [[Antiarrhythmics\|AMIODARONE]] 300 mg IVP, IO.		** [[Antiarrhythmics\|AMIODARONE]] 300 mg IVP, IO.

Treloars: /* When the Patient found in cardiac arrest: */

2013-03-19T14:26:52Z

When the Patient found in cardiac arrest:

← Older revision		Revision as of 14:26, 19 March 2013
Line 41:		Line 41:
	** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)		** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)
	* Administer [[Adrenergics\|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest		* Administer [[Adrenergics\|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest
	'''OR'''		:'''OR'''
	* Administer [[Hormones Vitamins\|VASOPRESSIN]] 40 units IV / IO – replaces the first or second dose of epinephrine		* Administer [[Hormones Vitamins\|VASOPRESSIN]] 40 units IV / IO – replaces the first or second dose of epinephrine
	** Vasopressin is a one-time dose		** Vasopressin is a one-time dose
Line 48:		Line 48:
	** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic		** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic
	** Subsequent shocks should be at the higher dose selected		** Subsequent shocks should be at the higher dose selected
	*Administer [[Antiarrhythmics\|LIDOCAINE]] 1 to 1.5 mg/kg IVP. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.		* Administer antidysrhythmic medication:
			** [[Antiarrhythmics\|AMIODARONE]] 300 mg IVP, IO.
			** May repeat second dose [[Antiarrhythmics\|AMIODARONE]] (if needed) 150 mg IV, IO in 3-5 minutes.
			*** Maximum dose 450 mg.
			:'''OR'''
			* Administer [[Antiarrhythmics\|LIDOCAINE]] 1 to 1.5 mg/kg IVP, IO. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.
	** In patients over age 70 or in those with known hepatic disease, administer [[Antiarrhythmics\|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.		** In patients over age 70 or in those with known hepatic disease, administer [[Antiarrhythmics\|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.
	** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[Antiarrhythmics\|LIDOCAINE]] DRIP 1-4 mg/min.		** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[Antiarrhythmics\|LIDOCAINE]] DRIP 1-4 mg/min.

Treloars: /* When the Patient found in cardiac arrest: */

2013-03-18T15:05:27Z

When the Patient found in cardiac arrest:

← Older revision		Revision as of 15:05, 18 March 2013
Line 48:		Line 48:
	** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic		** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic
	** Subsequent shocks should be at the higher dose selected		** Subsequent shocks should be at the higher dose selected
	* Administer [[Antiarrhythmics\|LIDOCAINE]] 1 to 1.5 mg/kg IVP. May repeat every 5-10 minutes to a maximum of 3 mg/Kg		*Administer [[Antiarrhythmics\|LIDOCAINE]] 1 to 1.5 mg/kg IVP. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.
	** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a LIDOCAINE DRIP 1-4 mg/min		** In patients over age 70 or in those with known hepatic disease, administer [[Antiarrhythmics\|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.
	** In patients over age 70 or in those with known hepatic disease, ~~reduce~~ [[Antiarrhythmics\|LIDOCAINE]] ~~boluses to 0.25~~ mg/~~kg every 3 minutes to a maximum of 1~~.~~5 mg/kg~~		** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[Antiarrhythmics\|LIDOCAINE]] DRIP 1-4 mg/min.
			** In patients over age 70 or in those with known hepatic disease, administer [[Antiarrhythmics\|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.
	* Administer [[Electrolytes\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)		* Administer [[Electrolytes\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)
	* Administer [[Electrolytes\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD		* Administer [[Electrolytes\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD

← Older revision		Revision as of 13:44, 24 April 2020
Line 58:		Line 58:
	** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[Lidocaine\|LIDOCAINE]] DRIP 1-4 mg/min.		** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[Lidocaine\|LIDOCAINE]] DRIP 1-4 mg/min.
	** In patients over age 70 or in those with known hepatic disease, administer [[Lidocaine\|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.		** In patients over age 70 or in those with known hepatic disease, administer [[Lidocaine\|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.
	* Administer [[~~Electrolytes~~\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)		* Administer [[Magnesium Sulfate\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)
	* Administer [[~~Electrolytes~~\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD		* Administer [[Sodium Bicarbonate\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD

	'''If patient combative post resuscitation, refer to [[Analgesia and Sedation\|ANALGESIA / SEDATION PARAMETER (2.04)]]'''		'''If patient combative post resuscitation, refer to [[Analgesia and Sedation\|ANALGESIA / SEDATION PARAMETER (2.04)]]'''

← Older revision		Revision as of 23:37, 23 April 2020
Line 50:		Line 50:
	''If after 3 attempts at defibrillation and patient is still presenting VF, consider using double sequential defibrillation for subsequent shocks at 720j biphasic. If two manual monitors are not available, use one monitor and one AED even though they will not be able to deliver full 720j. (using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])		''If after 3 attempts at defibrillation and patient is still presenting VF, consider using double sequential defibrillation for subsequent shocks at 720j biphasic. If two manual monitors are not available, use one monitor and one AED even though they will not be able to deliver full 720j. (using [https://www.youtube.com/watch?v=Ov-BBUhKdJU double sequential defibrillation])
	* Administer antidysrhythmic medication:		* Administer antidysrhythmic medication:
	** [[~~Antiarrhythmics~~\|AMIODARONE]] 300 mg IVP, IO.		** [[Amiodarone\|AMIODARONE]] 300 mg IVP, IO.
	** May repeat second dose [[~~Antiarrhythmics~~\|AMIODARONE]] (if needed) 150 mg IV, IO in 3-5 minutes.		** May repeat second dose [[Amiodarone\|AMIODARONE]] (if needed) 150 mg IV, IO in 3-5 minutes.
	*** Maximum dose 450 mg.		*** Maximum dose 450 mg.
	:'''OR'''		:'''OR'''
	* Administer [[~~Antiarrhythmics~~\|LIDOCAINE]] 1 to 1.5 mg/kg IVP, IO. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.		* Administer [[Lidocaine\|LIDOCAINE]] 1 to 1.5 mg/kg IVP, IO. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.
	** In patients over age 70 or in those with known hepatic disease, administer [[~~Antiarrhythmics~~\|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.		** In patients over age 70 or in those with known hepatic disease, administer [[Lidocaine\|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.
	** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[~~Antiarrhythmics~~\|LIDOCAINE]] DRIP 1-4 mg/min.		** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[Lidocaine\|LIDOCAINE]] DRIP 1-4 mg/min.
	** In patients over age 70 or in those with known hepatic disease, administer [[~~Antiarrhythmics~~\|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.		** In patients over age 70 or in those with known hepatic disease, administer [[Lidocaine\|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.
	* Administer [[Electrolytes\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)		* Administer [[Electrolytes\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)
	* Administer [[Electrolytes\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD		* Administer [[Electrolytes\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD

← Older revision		Revision as of 15:05, 18 March 2013
Line 48:		Line 48:
	** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic		** VF/VT Present – deliver a DEFIBRILLATION 300-360j biphasic
	** Subsequent shocks should be at the higher dose selected		** Subsequent shocks should be at the higher dose selected
	* Administer [[Antiarrhythmics\|LIDOCAINE]] 1 to 1.5 mg/kg IVP. May repeat every 5-10 minutes to a maximum of 3 mg/Kg		*Administer [[Antiarrhythmics\|LIDOCAINE]] 1 to 1.5 mg/kg IVP. May repeat every 5-10 minutes to a maximum of 3 mg/Kg.
	** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a LIDOCAINE DRIP 1-4 mg/min		** In patients over age 70 or in those with known hepatic disease, administer [[Antiarrhythmics\|LIDOCAINE]] gradually up to a full initial loading dose or until a maximum of 1.5 mg/kg administered.
	** In patients over age 70 or in those with known hepatic disease, ~~reduce~~ [[Antiarrhythmics\|LIDOCAINE]] ~~boluses to 0.25~~ mg/~~kg every 3 minutes to a maximum of 1~~.~~5 mg/kg~~		** If VF/VT converts to a pulse-producing non-heart block supraventricular rhythm, administer a [[Antiarrhythmics\|LIDOCAINE]] DRIP 1-4 mg/min.
			** In patients over age 70 or in those with known hepatic disease, administer [[Antiarrhythmics\|LIDOCAINE]] DRIP at the lower 1-2 mg/min. MONITOR FOR SIGNS OF TOXICITY including seizure activity.
	* Administer [[Electrolytes\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)		* Administer [[Electrolytes\|MAGNESIUM SULFATE]] 2 gm IVP only if suspected Polymorphic VT (Torsades de pointes) or hypomagnesemic state (chronic alcohol, diuretic use)
	* Administer [[Electrolytes\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD		* Administer [[Electrolytes\|SODIUM BICARBONATE]] 1 mEq/kg IVP if suspected, HYPERKALEMIA (e.g. dialysis patient), or Tricyclic antidepressant OD